The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Is The Expected Market Size Of The Personal Genome Services Market In 2026 And How Much Will It Reach By 2030?

The personal genome services market has experienced significant expansion in recent years. It is projected to grow from $6.84 billion in 2025 to $7.85 billion in 2026, achieving a compound annual growth rate (CAGR) of 14.7%. The market’s historical growth can be attributed to factors such as reduced sequencing costs, an increase in demand for ancestry testing, greater consumer awareness of genetics, the proliferation of genomics startups, and enhanced sequencing accuracy.

The personal genome services market is projected to experience swift expansion in the coming years. This market is anticipated to reach $13.69 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 14.9%. Several factors will drive this expansion during the forecast period, including an increase in preventive genomics adoption, wider application of pharmacogenomics, growing consumer demand for personalized wellness solutions, more extensive insurance coverage for testing, and the integration with digital health platforms. Significant developments expected in this timeframe comprise direct-to-consumer genome testing, comprehensive health risk genomic reports, bundled pharmacogenomic services, preventive genome screening packages, and digital platforms for genetic counseling.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=33258&type=smp

Which Strategic Drivers Are Supporting The Personal Genome Services Market Development?

The personal genome services market is projected to expand due to the heightened emphasis on personalized medicine. Personalized medicine represents a healthcare strategy that tailors treatment and preventive measures according to an individual’s unique genetic, biological, and lifestyle attributes. The growing acceptance of personalized medicine stems from breakthroughs in genomics and molecular diagnostics, enabling the customization of treatments to an individual’s genetic makeup for improved results. Through the analysis of an individual’s genetic profile, personal genome services facilitate personalized medicine, aiding in disease risk prediction, guiding medication choices, and customizing prevention and treatment plans. As an illustration, data from February 2024 by the Personalized Medicine Coalition, a US-based non-profit organization, indicated that in 2023, the FDA sanctioned 16 novel personalized treatments for rare disease patients, an increase from six in 2022. The personalized treatments newly approved for 2023 further comprised seven cancer drugs and three for various other diseases and conditions. Consequently, the heightened attention on personalized medicine is fueling the expansion of the personal genome services market.

What Are The Core Segment Classifications In The Personal Genome Services Market?

The personal genome services market covered in this report is segmented –

1) By Service Type: Genetic Testing; Whole Genome Sequencing; Carrier Testing; Ancestry Testing; Other Service Types

2) By Application: Healthcare; Research; Ancestry; Other Applications

3) By End-User: Hospitals and Clinics; Research Centers; Direct-to-Consumer; Other End-Users

Subsegments:

1) By Genetic Testing: Health Risk Assessment Testing; Pharmacogenomic Testing; Nutritional Genetic Testing; Lifestyle Genetic Testing; Wellness Genetic Screening

2) By Whole Genome Sequencing: Clinical Whole Genome Sequencing; Research Whole Genome Sequencing; Preventive Health Genome Sequencing; Rare Disease Genome Sequencing; Population Based Genome Sequencing

3) By Carrier Testing: Inherited Disease Carrier Screening; Preconception Carrier Testing; Prenatal Carrier Testing; Reproductive Health Carrier Screening; Family Planning Carrier Testing

4) By Ancestry Testing: Ethnicity Estimation Testing; Genealogical Lineage Testing; Migration Pattern Analysis; Regional Ancestry Breakdown; Family Relationship Discovery

5) By Other Service Types: Newborn Genetic Screening; Predictive Genetic Testing; Sports Performance Genetic Analysis; Personalized Health Reporting; Custom Genetic Consulting Services

Which Trends Are Shaping The Personal Genome Services Market Landscape?

Leading firms within the personal genome services market are concentrating on creating sophisticated offerings, including genome-wide risk stratification, to deliver tailored health information, forecast disease vulnerability, and inform both preventative measures and lifestyle adjustments. This stratification involves examining a person’s complete genome to pinpoint genetic variations linked to the likelihood of developing specific diseases or conditions, thereby allowing for customized health risk predictions and focused prevention approaches. An example of this is MyOme Inc., a US-based biotechnology firm, which introduced the initial integrated polygenic risk score (iPRS) test for prostate cancer in November 2025. This test integrates ~7 million genetic markers with clinical data to provide individualized risk projections over 10 years and a lifetime, with its accuracy confirmed in 140,000+ diverse men. The objective is early detection and prevention for 95% of cases lacking rare variants like BRCA2. It directs PSA, MRI, or biopsies for individuals deemed high-risk (those with 3-4x elevated odds in the top decile), simultaneously reducing instances of false positives and unnecessary treatments. Its advantages encompass precise stratification, equitable performance across ancestries, and continuously updated insights powered by AI, all derived from one whole-genome sample.

Which Companies Are Engaged In The Personal Genome Services Market Environment?

Major companies operating in the personal genome services market are Thermo Fisher Scientific Inc, Illumina Inc, Helix OpCo LLC, Ancestry.com Operations Inc, Fulgent Genetics Inc, 23andMe Holding Co, Prenetics Global Limited, MyHeritage Ltd, Color Health Inc, Genomics plc, GenoPalate Inc, Living DNA Ltd, Mapmygenome India Pvt Ltd, Nebula Genomics Inc, Xcode Life Sciences Pvt Ltd, Sema4 Holdings Corp, Gene by Gene Ltd, TellmeGen SL, CRI Genetics LLC, African Ancestry Inc, and DNAFit Limited.

Access The Complete Personal Genome Services Market Report:

https://www.thebusinessresearchcompany.com/report/personal-genome-services-market-report

Which Region Leads The Personal Genome Services Market By Size?

North America was the largest region in the personal genome services market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the personal genome services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Customized Personal Genome Services Market Report for Deeper Competitive Insights

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model